title: Potency and selectivity of the aromatase inhibitor R 76,713. A study in human ovarian, adipose stromal, testicular and adrenal cells.
abstract: The effects of R 76,713 on steroidogenesis were studied in primary cultures of four different human cell types, i.e. ovarian granulosa cells, adipose stromal cells, testicular cells and adrenal cells. In human granulosa cells aromatization of [1 beta, 2 beta-3H]androstenedione (as measured by the release of tritiated water) showed a Km (Michaelis constant) of 78 nM. R 76,713 competitively inhibited aromatization with a Ki (dissociation constant of the enzyme-inhibitor complex) of 1.6 nM. In human adipose stromal cells aromatization was measured by following the conversion of androstenedione to estrone and 17 beta-estradiol. In this system a Km for aromatization of androstenedione of 10.8 nM was found. R 76,713 again showed competitive kinetics with a Ki-value of 0.14 nM. In human testicular cells the synthesis of the androgens testosterone, androstenedione and dehydroepiandrosterone was only inhibited by drug concentrations exceeding 10(-6) M. At 10(-5) M of R 76,713, steroid concentrations were lowered to 56, 64 and 81% of the control for testosterone, androstenedione and dehydroepiandrosterone respectively. Concomitantly, a slight increase in the levels of pregnenolone (138% of the control) and progesterone (133% of the control) was seen. In human adrenal cells the synthesis of cortisol and aldosterone was slightly affected by R 76,713 also at concentrations exceeding 10(-6) M. At 10(-5) M of R 76,713 the concentrations of cortisol and aldosterone were lowered to respectively 59 and 51% of the control. At the same drug concentration the precursors 11-deoxycortisol and 11-deoxycorticosterone rose to 189 and 147% of the control. These results show that in primary cultures of human cells, R 76,713 is a very potent aromatase inhibitor with a selectivity of at least 1000-fold compared to other steps in steroidogenesis.
authors.affiliation: Department of Endocrinology and Oncology, Janssen Research Foundation, Beerse, Belgium.
authors.forename: W
authors.initials: W
authors.lastname: Wouters
authors.forename: R
authors.initials: R
authors.lastname: De Coster
authors.forename: D
authors.initials: D
authors.lastname: Beerens
authors.forename: R
authors.initials: R
authors.lastname: Doolaege
authors.forename: J A
authors.initials: JA
authors.lastname: Gruwez
authors.forename: K
authors.initials: K
authors.lastname: Van Camp
authors.forename: H
authors.initials: H
authors.lastname: Van Der Pas
authors.forename: B
authors.initials: B
authors.lastname: van Herendael
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects* / Q000378:metabolism; D000311:Adrenal Glands / Q000187:drug effects* / Q000378:metabolism; D047072:Aromatase Inhibitors; D001667:Binding, Competitive; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism; D013256:Steroids / Q000096:biosynthesis*; D013737:Testis / Q000187:drug effects* / Q000378:metabolism; D014230:Triazoles / Q000494:pharmacology*
chemical_list: D047072:Aromatase Inhibitors; D013256:Steroids; D014230:Triazoles; C060523:vorozole